PDS Biotechnology Corp. PDSB 深 滬
已收盤 02-06 16:00:00 美东时间
0.715
+0.025
+3.59%
華盛通- 最 高0.7409
- 今 開0.69
- 成交量 44.99万股
- 最 低 0.6811
- 昨 收 0.6902
- 總市值 3777.02万
- 52周最高 2.20
- 市盈率 靜 --
- 換手率 0.85%
- 52周最低 0.6794
- 委 比 91.49%
- 總股本 5282.55万
- 歷史最高 17.85
- 量 比 0.62
- 振 幅 8.66%
- 歷史最低 0.615
- 每 手 1
- 風險率 0.24%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多PDS Biotechnology Announces U.S. Patent Office Issues Notice Of Allowance For Its PDS0101 Asset
PDS Biotechnology Corporation (NASDAQ:PDSB) ("PDS Biotech" or the "Company"), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced that the U.S.
01-22 21:46
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers MoonLake (NASDAQ:MLTX) stock rose 8.2% to $20.0 during Friday's after-...
01-10 05:05
PDS Biotechnology Submits Protocol Amendment To FDA For Its Phase 3 VERSATILE-003 Study
PDS Biotechnology Corporation (Nasdaq: PDSB) ("PDS Biotech" or the "Company"), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced that the Company
01-09 21:47
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Athira Pharma (NASDAQ:ATHA) stock increased by 30.6% to $5.4 during Th...
2025-12-18 20:05
PDS Biotech Secures New Japan Patent Granting Broad Protection For PDS0101, Extending Global IP Coverage Into The 2040s
New Patent Grants Broad Composition Claims for PDS0101Previously Granted Patent Protections and Anticipated Market Exclusivity Provide Protection for PDS0101 in the United States into the 2040sPRINCETON, N.J., Dec. 09,
2025-12-09 21:08
美股大行评级 | 安捷伦科技、Keysight、先科电子获多家大行上调目标价；摩根大通下调亿航智能评级至"中性"，目标价下调至13美元
今日重点评级关注：HC Wainwright & Co.：维持BiomX"买入"评级，目标价从15美元升至26美元；Clear Street：维持Diversified Energy"买入"评级，目标价从23美元升至25美元
2025-11-26 10:07
B. Riley Securities Maintains Buy on PDS Biotechnology, Lowers Price Target to $3
B. Riley Securities analyst Kalpit Patel maintains PDS Biotechnology (NASDAQ:PDSB) with a Buy and lowers the price target from $5 to $3.
2025-11-26 02:14
美股大行评级 | 思科、On Holding、派拓网络等获多家机构上调目标价；Circle 遭富国、德银等多家机构下调目标价
今日重点评级关注：HC Wainwright & Co.：维持PDS Biotechnology"买入"评级，目标价从13美元升至15美元；HC Wainwright & Co.：维持PepGen Inc."买入"评级，目标价从18美元升至20美元
2025-11-14 10:43
PDS Biotechnology Q3 EPS $(0.19) Beats $(0.22) Estimate
PDS Biotechnology (NASDAQ:PDSB) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.22) by 13.64 percent. This is a 34.48 percent increase over losses of $(0.29) per share from
2025-11-13 20:31
Earnings Scheduled For November 13, 2025
Companies Reporting Before The Bell • Edgewell Personal Care (NYSE:EPC) is proj...
2025-11-13 19:11
